The Business Research Company’s report on the Comprehensive Metabolic Panel (CMP) Testing Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.
What are the key drivers behind the comprehensive metabolic panel (cmp) testing market’s growth in recent years?
The increasing prevalence of cardiovascular diseases and diabetes is expected to propel the growth of the comprehensive metabolic panel (CMP) testing market going forward. Cardiovascular disorders affect the heart or blood vessels and are linked to atherosclerosis, the build-up of fatty deposits inside the arteries. Diabetes is a condition that develops when blood glucose levels are too high. Comprehensive metabolic panel (CMP) blood tests detect glucose levels. Thus, with the increasing cases of diabetes and cardiovascular diseases, the need for their diagnosis through blood tests such as the CMP blood test will support the market’s growth. For instance, in December 2023, according to the Australian Institute of Health and Welfare, an Australia-based national agency that oversees public health and wellness, there were 13,700 doctor-certified fatalities attributable to CHD in 2020, increasing to 14,100 in 2021 and 14,900 in 2022. Furthermore, in June 2022, according to the International Diabetes Federation, a Belgium-based diabetes federation, the prevalence of diabetes had increased to 10.5% worldwide, with over half (44.7%) of people still undiagnosed. Therefore, the increasing prevalence of cardiovascular diseases and diabetes is driving the growth of the comprehensive metabolic panel (CMP) testing market.
Access Your Free Sample of the Global Comprehensive Metabolic Panel (CMP) Testing Market Report – Get Insights Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12362&type=smp
How does the future projection of the comprehensive metabolic panel (cmp) testing market size compare to its historical growth?
The comprehensive metabolic panel (CMP) testing market size has grown strongly in recent years. It will grow from $17.04 billion in 2024 to $18.39 billion in 2025 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to a rise in chronic diseases, demand for holistic health assessments, healthcare system emphasis on preventive care, rise in lifestyle-related conditions, and patient-centric healthcare approach
The comprehensive metabolic panel (CMP) testing market size is expected to see strong growth in the next few years. It will grow to $26.02 billion in 2029 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to personalized medicine and precision healthcare, integration of CMP testing in telehealth services, demand for comprehensive health screenings, rise in wellness and preventive health initiatives, and evolving healthcare policies and regulations. Major trends in the forecast period include continuous monitoring and longitudinal tracking, telemedicine-friendly reporting formats, standardization of reference ranges, integration of wearable health technology, and emphasis on patient education and engagement.
Gain Exclusive Market Insights—Customize Your Research Report Today For Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=12362&type=smp
Which key players are shaping the future of the comprehensive metabolic panel (cmp) testing market?
Major companies operating in the comprehensive metabolic panel (CMP) testing market include Abbott Laboratories Inc., Siemens Healthineers AG, Mayo Clinic, Laboratory Corporation of America Holdings, Mercy, Mount Sinai Health System, Quest Diagnostics Incorporated, Sonic Healthcare Limited, Hologic Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., Werfen SA, DiaSorin S.p.A., Randox Laboratories Ltd., ARUP Laboratories Inc., Invitae Corporation, Abaxis Inc., Metropolis Healthcare Limited, Clinical Reference Laboratory (CRL), Centogene AG, Spectra Laboratories, Unipath Systems Ltd., Scion Lab Services LLC, Weldon Biotech Pvt Ltd., Corona Pathology,Ulta Lab Tests LLC, Any Lab Test Now, Applied InGENuity Diagnostics LLC, Walk-In Lab LLC
What trends will propel the growth and evolution of the comprehensive metabolic panel (cmp) testing market?
Technological advancements are a key trend gaining popularity in the comprehensive metabolic panel (CMP) testing market. Major companies operating in the comprehensive metabolic panel (CMP) testing market are developing new technologies to sustain their position in the market. For instance, in April 2022, HealthifyMe, an Indian-based wellness and fitness services company, launched HealthifyPro, a flagship fitness plan. The HealthifyPro plan’s metabolic panel is based on a blood test that may measure more than 80 different factors. The main components of HealthifyPro that are included to track users’ health are a biosensor system (BIOS), a smart scale, health coaches, HealthifyMe’s AI assistant, and a metabolic panel. It integrates data on glucose patterns with the users’ food consumption and other exercise behaviors to create a personalized approach for each user.
Which regions are expected to become dominant players in the comprehensive metabolic panel (cmp) testing market?
North America was the largest region in the comprehensive metabolic panel (CMP) testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the comprehensive metabolic panel (CMP) testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Order Your Report Now For Swift Delivery
What are the emerging key segments in the comprehensive metabolic panel (cmp) testing market, and how are they evolving?
The comprehensive metabolic panel (CMP) testing market covered in this report is segmented –
1) By Disease: Kidney Disease, Liver Disease, Diabetes, Other Diseases
2) By Test Type: Proteins, Electrolytes, Kidney Tests, Liver Functional Tests, Glucose
3) By End User: Laboratories, Point Of Care (PoC)
Subsegments:
1) By Kidney Disease: Chronic Kidney Disease (CKD), Acute Kidney Injury (AKI), Glomerulonephritis
2) By Liver Disease: Hepatitis (Viral And Non-Viral), Cirrhosis, Fatty Liver Disease
3) By Diabetes: Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes
4) By Other Diseases: Cardiovascular Diseases, Electrolyte Imbalances, Metabolic Disorders, Pancreatic Diseases
Purchase The Exclusive Report Now To Unlock Valuable Market Insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12362
What defines the structure and scope of the comprehensive metabolic panel (cmp) testing market?
A comprehensive metabolic panel (CMP) test is a blood test containing 14 separate parameters that offer crucial knowledge about the body’s chemical equilibrium and metabolism. It is frequently used to assess nutritional levels, liver and kidney function, and diagnosis, screening, and monitoring.
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
